Paper · 41895280
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
Bandlamudi C and 88 others. Cancer Cell, 2026. Cited by 4 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cancer type-specific variation in patterns of driver alterations across 50,000 tumors. Papers, record 41895280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41895280
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms | Major topic |
| Mutation | Major topic |
| Humans | |
| HLA Antigens |
Source PubMed
Grants12
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P50 CA272170 | NCI NIH HHS | United States | P50CA272170 | PubMed | NIH RePORTER |
| U24 CA220457 | NCI NIH HHS | United States | U24CA220457 | PubMed | NIH RePORTER |
| R35 CA305347 | NCI NIH HHS | United States | R35CA305347 | PubMed | NIH RePORTER |
| R01 CA286507 | NCI NIH HHS | United States | R01CA286507 | PubMed | NIH RePORTER |
| R01 CA227534 | NCI NIH HHS | United States | R01CA227534 | PubMed | NIH RePORTER |
| R25 CA233208 | NCI NIH HHS | United States | R25CA233208 | PubMed | NIH RePORTER |
| P50 CA221745 | NCI NIH HHS | United States | P50CA221745 | PubMed | NIH RePORTER |
| R35 NS105109 | NINDS NIH HHS | United States | R35NS105109 | PubMed | NIH RePORTER |
| P50 CA257881 | NCI NIH HHS | United States | P50CA257881 | PubMed | NIH RePORTER |
| R35 CA263816 | NCI NIH HHS | United States | R35CA263816 | PubMed | NIH RePORTER |
1 to 10 of 12
See all 12 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42,001,850 | Cancer type-specific variation in patterns of driver alterations across 50,000 tumors. | https://conductscience.org/library/papers/42001850 |
Source PubMed
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39,670,006 | EGFR-V834L combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer. | Transl Lung Cancer Res | 2024 | https://conductscience.org/library/papers/39670006 | PubMed |
| 2 | 31,839,416 | Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib. | Lung Cancer | 2020 | https://conductscience.org/library/papers/31839416 | PubMed |
| 3 | 33,625,877 | OncoTree: A Cancer Classification System for Precision Oncology. | JCO Clin Cancer Inform | 2021 | https://conductscience.org/library/papers/33625877 | PubMed |
| 4 | 18,772,396 | An integrated genomic analysis of human glioblastoma multiforme. | Science | 2008 | https://conductscience.org/library/papers/18772396 | PubMed |
| 5 | 2,188,735 | A genetic model for colorectal tumorigenesis. | Cell | 1990 | https://conductscience.org/library/papers/2188735 | PubMed |
| 6 | 39,602,136 | Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies. | JAMA Oncol | 2025 | https://conductscience.org/library/papers/39602136 | PubMed |
| 7 | 30,872,507 | Tissue-specificity in cancer: The rule, not the exception. | Science | 2019 | https://conductscience.org/library/papers/30872507 | PubMed |
| 8 | 32,025,013 | The evolutionary history of 2,658 cancers. | Nature | 2020 | https://conductscience.org/library/papers/32025013 | PubMed |
| 9 | 23,348,506 | Highly recurrent TERT promoter mutations in human melanoma. | Science | 2013 | https://conductscience.org/library/papers/23348506 | PubMed |
| 10 | 27,270,079 | FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27270079 | PubMed |
1 to 10 of 92
See all 92 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,353,852 | Domain-Level Distribution of Pathogenic BRCA1/2 Somatic Mutations Shows No Evidence of Large Subtype-Specific Enrichment in Breast Cancer: A Three-Cohort Analysis Supporting Broad BRCA Testing. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42353852 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41895280
GET https://conductscience.org/api/papers/v1/41895280/authors?page=2